Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients.
Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier.
Glio-vascular modifications caused by Aquaporin-4 deletion in the mouse retina.
Nanovesicle-based platform for the electrophysiological monitoring of aquaporin-4 and the real-time detection of its antibody.
Intractable pruritus in neuromyelitis optica.
MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study.
Olfactory Dysfunction in Multiple Sclerosis: Evidence of a Decrease in Different Aspects of Olfactory Function.
Movement Strategies for Maintaining Standing Balance during Arm Tracking in People with Multiple Sclerosis.
Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis.
Epigenetic regulation of polyomavirus JC involves acetylation of specific lysine residues in NF-κB p65.
Skeletal muscle findings in experimental autoimmune encephalomyelitis.
Clinical, radiographic characteristics and immunomodulating changes in neuromyelitis optica with extensive brain lesions.
Astrocyte matricellular proteins that control excitatory synaptogenesis are regulated by inflammatory cytokines and correlate with paralysis severity during experimental autoimmune encephalomyelitis.
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
Treatment with tanshinone IIA suppresses disruption of the blood-brain barrier and reduces expression of adhesion molecules and chemokines in experimental autoimmune encephalomyelitis.
Brain atrophy: an in-vivo measure of disease activity in multiple sclerosis.
Applications of optical coherence tomography in pediatric clinical neuroscience.
Total glucosides of peony attenuates experimental autoimmune encephalomyelitis in C57BL/6 mice.
The association between fatigue and apathy in patients with either Parkinson's disease or multiple sclerosis.
Multiple sclerosis: Daclizumab HYP shows superiority to IFN-β1a for reducing relapses in multiple sclerosis.
Autoimmune encephalitis in humans: how closely does it reflect multiple sclerosis ?
Multiple sclerosis: autoimmunity and viruses.
The Neurocognitive Profile of the Cerebellum in Multiple Sclerosis.
Incidence of multiple sclerosis among European Economic Area populations, 1985-2009: the framework for monitoring.
Inadequacy of Clinical Trial Designs and Data to Control for the Confounding Impact of Race/Ethnicity in Response to Treatment in Multiple Sclerosis.

Pages